presentación de powerpoint - eu-lac...
TRANSCRIPT
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
Horizon2020 SC1 – Health, Demographic change and Wellbeing – Opportunities in Health (2016-2017)”
1
Caterina Buonocore NCP SC1 “Health, Demographic change and Wellbeing”
APRE - Italy
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
AGENDA
Context H2020
Opportunities in Health
Next Work Programme 2018-2020
2
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
Health Research & Innovation in H2020
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
Health Research in H2020
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
Excellent Science
European Research Council
Frontier research by the best individual teams
Future and Emerging Technologies
Collaborative research to open new fields of innovation
Marie Skłodowska Curie actions
Opportunities for training and career development
Research infrastructures (including e-infrastructure)
Ensuring access to world-class facilities
Industrial Technologies
Leadership in enabling and industrial technologies
ICT, nanotechnologies, materials, biotechnology, manufacturing, space
Access to risk finance
Leveraging private finance and venture capital for research and innovation
Innovation in SMEs
Fostering all forms of innovation in all types of SMEs
Societal Challenges
Health, demographic change and wellbeing
Food security, sustainable agriculture, marine and maritime research & the bioeconomy
Secure, clean and efficient energy
Smart, green and integrated transport
Climate action, resource efficiency and raw materials
Inclusive, innovative and reflective societies
Secure societies
European Institute of Innovation and Technology (EIT)
Spreading Excellence and Widening Participation
Science with and for society
Joint Research Center (JRC)
Structure of Horizon 2020
5
HEALTH
INDIVIDUAL RESEARCHER doing High risk/frontier Research
ERC
INDIVIDUAL RESEARCHER targeting dev. of research career and training
MSCA
GROUP of researchers/actors doing basic/visionary but feasible research on technological aspects FET
GROUP of researchers/actors doing research on
Key enabling Technologies
NMP-b
ICT
Materials
ONE or more SME developing
solutions close to market
GROUP of Researchers/actors doing collaborative
multidisciplinary research
SME Instrument
SC1, 2, 3, 7..
STRUCTURE OF THE PROGRAMME: WHERE HEALTH could fit?
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
References in current WP 2016-17
Sentence in Introduction "Health challenges are global (…) include the international dimension…"
Reference to international dimension and/or to specific multi-lateral initiatives:
• SC1-PM-01; SC1-PM-03; SC1-PM-06; SC1-PM-08; SC1- PM-14; SC1-HCO-04; SC1-HCO-07; SC1-HCO-14
Some topics refer to specif countries
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
SC1 and international cooperation
Reference to specific multi-lateral initiatives
Mutual opening of research programmes with Third Countries (USA)
Funding of Third Countries entities by their own funding agencies for participating to Horizon 2020 (Switzerland, Australia)
Specific actions
SC1. HEALTH,
DEMOGRAPHIC
CHANGE
AND
WELLBEING
9
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
Less prescriptive topic texts
Two-year work programme
Stronger focus on end users
Broad topics
Pers. Medicine
Clinical trials
Work Programme SC1 2016-2017
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
Personalised medicine – towards a definition
"Personalised medicine refers to a medical model using
molecular profiling for tailoring the right therapeutic
strategy for the right person at the right time, and/or
to determine the predisposition to disease and/or to deliver
timely and targeted prevention"
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
SC1 Work Programme 2017 in brief
SME Instrument 2 topics (unchanged from 2016)
Other Actions 12 items (incl. InnovFin ID and Birth
Day Prize)
Including 'Coordination activities' 4 topics
Call 'Personalised Medicine' 11 topics
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
Health in H2020
Health solutions can imply different phases of research and innovation
13 INNOVATION
RESEARCH
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
Call Budget Deadline
SC1-PM-03–2017 New concepts in patient stratification
€15M 11 Apr.2017
SC1-PM-11–2017: Clinical research on regenerative medicine
€30M 11 Apr. 2017
SC1-PM-15-2017: Personalised coaching for well-being and care of people as they age
€25M 31 Jan. 2017
SC1-PM-16–2017: In-silico trials for developing and assessing biomedical products
€19M 14 Mar. 2017
SC1-PM-17 – 2017: Personalised computer models and in-silico systems for well-being
€19M 14 Mar. 2017
SC1-PM-19–2017: PPI for uptake of standards for the exchange of digitalised healthcare records
€8.26M 14 Mar. 2017
SC1-PM-20-2017: Development of new methods and measures for improved economic evaluation and efficiency measures in the health sector
€9M 11 Apr. 2017
SC1 topics – 2017
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
SC1 topics – 2017 – Other actions
SC1 Work Programme (updated at 25 July 2016) http://ec.europa.eu/research/participants/data/ref/h2020/wp/2016_2017/main/h2020-wp1617-health_en.pdf
Mostra Desktop.scf
Call Budget Deadline
SC1-HCO-08–2017:
Actions to bridge the divide in European health research and
innovation
€1M 11 Apr. 2017
SMEInst-05-2016-2017: (for EU SME’s)
Supporting innovative SMEs in the healthcare biotechnology
sector:
a. Cell technologies in medical applications
b. Clinical research for the validation of biomarkers and/or
diagnostic medical devices*
SMEInst-06-2016-2017:
SMEInst-06-2016-2017 - Accelerating market introduction of ICT
solutions for Health, Well-Being and Ageing Well
€53M (2016)
€57.3M (2017)
Multiple cut-off
dates in 2016 and
2017
InnovFin Infectious Diseases (InnovFin ID) Pilot €50M (2016)
€50M (2017)
From first quarter
of 2016
Inducement prize on reducing maternal and new-born
morbidity and mortality - Birth Day Prize €1M 2017
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
• Adoption planned for 4th quarter 2017 • Strategic Programme - Draft Scoping Paper for SC1:
Next SC1 Work Programme 2018-2020
• Priority 1: Better health and care, economic growth and sustainable health systems
a. Personalized medicine
b. Innovative health and care industry
c. Improving global health
d. Sustainable and evidence-based health and care systems
e. Innovative health and care delivery services – Integration of care
• Priority 2: Decoding the role of the overall environment for health and well-being
a. The human exposome
b. Global changes and health (possible contribution to focus area COP21)
• Priority 3: Digital transformation in Health and Care
a. eHealth and mHealth
b. ICT for Active and Healthy Ageing
• Priority 4: Trusted Big Data solutions and Cybersecurity for Health and Care
a. Trusted Big Data solutions for health and care
b. Cybersecurity for health and care
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
Open to the world Multi-lateral health research activities
www.irdirc.org http://intbir.nih.gov/
http://ihec-epigenomes.org/
https://icgc.org/
G2MC
www.gacd.org/
http://www.glopid-r.org/
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
Global Alliance for Chronic diseases (GACD): Mexico, Argentina e Brazil, Cuba (tbc)
Global Research Collaboration for Infectious Disease Preparedness (GloPID-R): Mexico, Argentina e Brazil, Cuba (tbc)
Joint Programmining Initiative on Anti-Microbial Resistance (JPIAMR): Argentina
Participation of LAC
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
Participation of LAC in Zika call
SC1-PM-22-2016: Addressing the urgent research gaps against the Zika virus and other emerging threats in Latin America
Country Participation
Participation in Retained Proposals
Argentina 1 1 Bolivia 1 0 Brazil 50 14
Colombia 6 3 Cuba 3 2
Dominican Republic 1 0 Ecuador 1 1
Guatemala 1 0 Mexico 3 2
Peru 1 0 Venezuela 1 0
3 projects funded: ZikaPLAN ZIKAction ZikAlliance
More info: https://ec.europa.eu/research/health/index.cfm?pg=area&areaname=zika
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
More info @
Horizon 2020 (general + funding) http://ec.europa.eu/research/participants/portal/desktop/en/home.html
International cooperation website http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-
cutting-issues/international-cooperation_en.htm
Funding of Third countries http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/hi/3cp art/h2020-hi-
3cpart_en.pdf
Associated countries
http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/hi/3cpart/h2020-hi-list-ac_en.pdf
EU-LAC HEALTH has received funding from the European Union`s Seventh Framework
Programme (FP7/2007-2013) under grant agreement n° 281459.
Thanks for your attention!
APRE Agenzia per la Promozione della Ricerca Europea
via Cavour, 71 00184 - Roma
www.apre.it Tel. (+39) 06-48939993
Fax. (+39) 06-48902550
Caterina Buonocore
Health NCP [email protected]